IMDX

Insight Molecular Diagnostics Inc. Common Stock
IMDX

Overview Fund Activity

26 hedge funds and large institutions have $20M invested in Insight Molecular Diagnostics Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 0 closing their positions.

Holders
26
Holders Change
+6
Holders Change %
+30%
% of All Funds
0.35%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
6
Increased
9
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BC
1
Broadwood Capital
New York
$14.9M
2
PVI
2
Pura Vida Investments
New York
$1.56M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$326K
4
TSS
4
Two Sigma Securities
New York
$31.5K
5
GSC
5
Ground Swell Capital
South Carolina
$26K

Top Sellers

1
AIC
1
AWM Investment Company
New York
$1.85M
2
DC
2
Defender Capital
North Carolina
$112K
3
Morgan Stanley
3
Morgan Stanley
New York
$147K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$576K
5
Osaic Holdings
5
Osaic Holdings
Arizona
$431
Name Market Value Shares Shares
Change 		Shares
Change %
AFG
26
Albion Financial Group
Utah
$17 7 – –
RhumbLine Advisers
27
RhumbLine Advisers
Massachusetts
– – – –
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
1
2